Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01005485 · ClinicalTrials.gov registry record
Molecular and Morphologic Characterization of Circulating Endothelial Cells
A clinical trial of Acute Myocardial Infarction, sponsored by Scripps Translational Science Institute.
- Active
- Registry status
- 664
- Enrollment target
- 1
- Study location
NCT01005485: Active study of Acute Myocardial Infarction, sponsored by Scripps Translational Science Institute.
NCT01005485 is a study of Acute Myocardial Infarction that is active but no longer recruiting, run by Scripps Translational Science Institute. The registered enrollment target is 664 participants, below the 1,847-participant average among 19 other Acute Myocardial Infarction trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01005485, a study of Acute Myocardial Infarction, is active but no longer recruiting, sponsored by Scripps Translational Science Institute.
- ACTIVE NOT RECRUITING
- Registry status
- 664 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary hypothesis of this study is that circulating endothelial cells (CECs) harbor key genetic and structural characteristics predisposing individuals to acute atherosclerotic plaque rupture and heart attack.
Conditions Studied
Study Locations (1)
California
- Scrippshealth - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 664 participants |
| Start Date | 2010-01 |
| Est. Completion | 2025-12 |
What the registry record for NCT01005485 still lists
NCT01005485 is an observational study that tracks outcomes without assigning an intervention. The registered 664 participants enrollment target is mid-sized for trials with a published cap, below the 1,847-participant average among 19 other Acute Myocardial Infarction trials with a reported enrollment target (64% lower).
The record links to 1 condition, with Acute Myocardial Infarction appearing as the primary indexed condition, and to 0 interventions.
NCT01005485 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01005485 about?
NCT01005485 is a clinical study titled "Molecular and Morphologic Characterization of Circulating Endothelial Cells". The primary hypothesis of this study is that circulating endothelial cells (CECs) harbor key genetic and structural characteristics predisposing individuals to acute atherosclerotic plaque rupture and heart attack.
What is the current status of trial NCT01005485?
This trial is currently active not recruiting. The enrollment target is 664 participants. The study started on 2010-01. Estimated completion is 2025-12.
What conditions does trial NCT01005485 study?
This clinical trial studies the following conditions: Acute Myocardial Infarction.
Who is sponsoring clinical trial NCT01005485?
This trial is sponsored by Scripps Translational Science Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01005485 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Myocardial Infarction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01005485's enrollment target sits among peer trials
664 8th of 19 higher than 12 of 19 other Acute Myocardial Infarction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Myocardial Infarction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.
RECRUITING · NA
-
Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock
RECRUITING
-
Abbott Vascular Medical Device Registry
RECRUITING
-
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
RECRUITING · NA
-
Arrhythmia Detection After MI
RECRUITING · NA
-
COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06607341 · 664 participants · NA
Community Engagement Alliance Against Disparities
- NCT04064060 · 665 participants · Phase 3
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
- NCT07164443 · 663 participants · Phase 3
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- NCT06328647 · 666 participants · NA
Quantra Point-of-Care Hemostasis Monitoring
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia